Gallstone disease primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

Effective measures for the primary prevention of gallstone disease include diet with sufficient fat and protein, maintaining a low body weight, and avoiding prolonged fasting.

Primary Prevention

Effective measures for prevention of gallstone disease include:^[1]^[2]^[3]^[4]

Eat three meals daily containing sufficient monounsaturated fat or protein, high in fiber and calcium, and low in saturated fats
Maintaining a low body weight
Regular exercise
During pregnancy maintain nutritional requirements
Patients receiving total parenteral nutrition (TPN) should be periodically assessed for possible enteral feeding

References

↑ Sitzmann JV, Pitt HA, Steinborn PA, Pasha ZR, Sanders RC (1990). “Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans”. Surg Gynecol Obstet. 170 (1): 25–31. PMID 2104681.
↑ Valdivieso V, Covarrubias C, Siegel F, Cruz F (1993). “Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium”. Hepatology. 17 (1): 1–4. PMID 8423030.
↑ Quigley EM, Marsh MN, Shaffer JL, Markin RS (1993). “Hepatobiliary complications of total parenteral nutrition”. Gastroenterology. 104 (1): 286–301. PMID 8419252.</ref *Daily injections of cholecystokinin or high doses of crystalline amino acids may promote gallbladder emptying and clearance of sludge in those on prolonged TPN *Patients with biliary sludge may benefit from prohylactic bile acid therapy<ref name=”pmid9499324″>Leitzmann MF, Giovannucci EL, Rimm EB, Stampfer MJ, Spiegelman D, Wing AL, Willett WC (1998). “The relation of physical activity to risk for symptomatic gallstone disease in men”. Ann. Intern. Med. 128 (6): 417–25. PMID 9499324.
↑ Leitzmann MF, Giovannucci EL, Rimm EB, Stampfer MJ, Spiegelman D, Wing AL, Willett WC (1998). “The relation of physical activity to risk for symptomatic gallstone disease in men”. Ann. Intern. Med. 128 (6): 417–25. PMID 9499324.

Template:WH Template:WS

[pmid2104681-1] Sitzmann JV, Pitt HA, Steinborn PA, Pasha ZR, Sanders RC (1990). “Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans”. Surg Gynecol Obstet. 170 (1): 25–31. PMID 2104681.

[pmid8423030-2] Valdivieso V, Covarrubias C, Siegel F, Cruz F (1993). “Pregnancy and cholelithiasis: pathogenesis and natural course of gallstones diagnosed in early puerperium”. Hepatology. 17 (1): 1–4. PMID 8423030.

[pmid8419252-3] Quigley EM, Marsh MN, Shaffer JL, Markin RS (1993). “Hepatobiliary complications of total parenteral nutrition”. Gastroenterology. 104 (1): 286–301. PMID 8419252.</ref *Daily injections of cholecystokinin or high doses of crystalline amino acids may promote gallbladder emptying and clearance of sludge in those on prolonged TPN *Patients with biliary sludge may benefit from prohylactic bile acid therapy<ref name=”pmid9499324″>Leitzmann MF, Giovannucci EL, Rimm EB, Stampfer MJ, Spiegelman D, Wing AL, Willett WC (1998). “The relation of physical activity to risk for symptomatic gallstone disease in men”. Ann. Intern. Med. 128 (6): 417–25. PMID 9499324.

[pmid9499324-4] Leitzmann MF, Giovannucci EL, Rimm EB, Stampfer MJ, Spiegelman D, Wing AL, Willett WC (1998). “The relation of physical activity to risk for symptomatic gallstone disease in men”. Ann. Intern. Med. 128 (6): 417–25. PMID 9499324.

[1]

[2]

[3]

[4]

Gallstone disease primary prevention

Overview

Primary Prevention

References

Looking for the patient version?